Your browser doesn't support javascript.
loading
Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.
Siu, Albert L; Bibbins-Domingo, Kirsten; Grossman, David C; Baumann, Linda Ciofu; Davidson, Karina W; Ebell, Mark; García, Francisco A R; Gillman, Matthew; Herzstein, Jessica; Kemper, Alex R; Krist, Alex H; Kurth, Ann E; Owens, Douglas K; Phillips, William R; Phipps, Maureen G; Pignone, Michael P.
Affiliation
  • Siu AL; Mount Sinai School of Medicine, New York, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York.
  • Bibbins-Domingo K; University of California, San Francisco.
  • Grossman DC; Group Health Research Institute, Seattle, Washington.
  • Baumann LC; University of Wisconsin, Madison.
  • Davidson KW; Columbia University, New York, New York.
  • Ebell M; University of Georgia, Athens.
  • García FA; Pima County Department of Health, Tucson, Arizona.
  • Gillman M; Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
  • Herzstein J; Independent consultant, Washington, DC.
  • Kemper AR; Duke University, Durham, North Carolina.
  • Krist AH; Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond.
  • Kurth AE; New York University, New York.
  • Owens DK; Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California.
  • Phillips WR; University of Washington, Seattle.
  • Phipps MG; Brown University, Providence, Rhode Island.
  • Pignone MP; University of North Carolina, Chapel Hill.
JAMA ; 315(7): 691-6, 2016 Feb 16.
Article in En | MEDLINE | ID: mdl-26881372
ABSTRACT
DESCRIPTION New US Preventive Services Task Force (USPSTF) recommendation on screening for autism spectrum disorder (ASD) in young children.

METHODS:

The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of brief, formal screening instruments for ASD administered during routine primary care visits and the benefits and potential harms of early behavioral treatment for young children identified with ASD through screening. POPULATION This recommendation applies to children aged 18 to 30 months who have not been diagnosed with ASD or developmental delay and for whom no concerns of ASD have been raised by parents, other caregivers, or health care professionals. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician. (I statement).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Advisory Committees / Autism Spectrum Disorder Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limits: Child, preschool / Humans / Infant Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2016 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Advisory Committees / Autism Spectrum Disorder Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limits: Child, preschool / Humans / Infant Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2016 Type: Article